Session Information
-
WCLC 2021
2022 World Conference on Lung Cancer
Presentation Date(s):- September 8 - 14, 2021
- Total Presentations: 1107
All times listed are in Mountain Time MDT (UTC-6:00)
PL - Plenary
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
FP - Featured Posters
P - Posters
WS - Workshops
IS - Industry Symposium
MTE - Meet the Expert
BEDG - Brain Exchange Discussion Groups
September 8 Wed
Sep 8 Thursday
September 9 Thu
Sep 9 Friday
September 10 Fri
Sep 10 Saturday
September 11 Sat
Sep 11 Sunday
September 12 Sun
Sep 12 Monday
September 13 Mon
Sep 13 Tuesday
September 14 Tue
Sep 14
-
+
P50 - Novel Therapeutics and Targeted Therapies - EGFR Minor
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P50.01 - RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19-del Variants
00:00 - 00:00 | Presenter: Kazumi Nishino
- Abstract
Loading... -
+
P50.03 - A Real-World Cohort Study of EGFR TKIs in Patients with NSCLC with Uncommon EGFR mutations (UpSwinG)
00:00 - 00:00 | Presenter: Satoru Miura
- Abstract
Loading... -
+
P50.04 - Amivantamab in Combination With Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Misako Nagasaka
- Abstract
Loading... -
+
P50.05 - Natural History and Real-World Treatment Outcomes for NSCLC Patients with EGFR Exon 20 Insertion Mutation: An IASLC- ASCO CancerLinQ Study
00:00 - 00:00 | Presenter: Madhusmita Behera
- Abstract
Loading... -
+
P50.06 - First-Line Therapy in NSCLC harbouring EGFR or HER2 Exon 20 Insertion Mutation. Hunting for the Best Candidate
00:00 - 00:00 | Presenter: Sara Manglaviti
- Abstract
Loading... -
+
P50.07 - Afatinib Treatment Response in Advanced Lung Adenocarcinomas Harboring Uncommon Mutations in Chinese Population
00:00 - 00:00 | Presenter: Teng Li
- Abstract
Loading... -
+
P50.08 - Targeting HER2 or EGFR Exon 20 Insertion Mutation in Lung Cancer - A Case Series from India
00:00 - 00:00 | Presenter: Vivek Joseph Varughese
- Abstract
Loading... -
+
P50.09 - Characteristics and Clinical Outcomes of HER2 Mutated Non-small Cell Lung Cancer Patients Detected by NGS in Routine Clinical Practice
00:00 - 00:00 | Presenter: Yejeong Han
- Abstract
Loading...
-
+
P51 - Novel Therapeutics and Targeted Therapies - EGFR Resistance
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P51.01 - Tepotinib Plus an EGFR TKI in Patients with EGFR-mutant NSCLC and Resistance to EGFR TKIs Due to MET Amplification (METamp)
00:00 - 00:00 | Presenter: Chong Kin Liam
- Abstract
Loading... -
+
P51.02 - Stacking on the Targets: Secondary Resistant, Potential Targetable Genetic Alterations in Patients With Epidermal Growth Factor Receptor NSCLC
00:00 - 00:00 | Presenter: Nagashree Seetharamu
- Abstract
Loading... -
+
P51.03 - Oritinib (SH-1028), a Third-generation EGFR-TKI in Advanced NSCLC Patients with Positive EGFR T790M: Results of a Single-arm Phase Ib Trial
00:00 - 00:00 | Presenter: Caicun Zhou
- Abstract
Loading... -
+
P51.04 - Pattern of Disease Progression on Osimertinib and Subsequent Treatment in Patients with EGFR- Mutated Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Hyesook Kim
- Abstract
Loading... -
+
P51.05 - Sequential Afatinib and Osimertinib in Patients With Advanced EGFRm+ NSCLC and Acquired T790M: The Real-World UpSwinG study
00:00 - 00:00 | Presenter: Sanjay Popat
- Abstract
Loading... -
+
P51.06 - Outcomes of First-Line TKI Treated Advanced NSCLC with Distinct Types of EGFR Mutations: Brain Metastasis and de Novo T790M
00:00 - 00:00 | Presenter: Ya Zeng
- Abstract
Loading... -
+
P51.07 - Small Cell Transformation of Non Small Cell Lung Carcinoma: Tissue Biopsy Is Here to Stay!
00:00 - 00:00 | Presenter: Mansi Sharma
- Abstract
Loading...
-
+
P52 - Novel Therapeutics and Targeted Therapies - KRAS
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P52.01 - Understanding Treatment Preferences of Patients With KRAS p.G12C[LC1] [MK2] – Mutated Advanced Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Kelley Myers
- Abstract
Loading... -
+
P52.02 - High SHP2 Expression Determines the Efficacy of PD-1/PD-L1 Inhibitors in Advanced KRAS Mutant Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Hui-Bo Feng
- Abstract
Loading... -
+
P52.03 - Efficacy of Sotorasib in KRAS p.G12C-Mutated NSCLC with Stable Brain Metastases: A Post-Hoc Analysis of CodeBreaK 100
00:00 - 00:00 | Presenter: Suresh Ramalingam
- Abstract
Loading... -
+
P52.04 - Histone Deacetylase 6 Inhibition Reveals Metabolic Vulnerabilities in KRAS Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Catriona M Dowling
- Abstract
Loading... -
+
P52.05 - Dual RAF/MEK Inhibitor VS-6766 for Treatment of KRAS Mutant NSCLC: Novel Combinations Targeting G12C or G12V Variants
00:00 - 00:00 | Presenter: Jonathan A Pachter
- Abstract
Loading...
-
+
P53 - Novel Therapeutics and Targeted Therapies - Others
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Novel Therapeutics and Targeted Therapies
-
+
P53.01 - Clinical Application of NGS Technology. Therapeutic Possibilities and Future Perspectives
00:00 - 00:00 | Presenter: Silvia Sequero-Lopez
- Abstract
Loading... -
+
P53.02 - Efficacy and Safety of Larotrectinib in Patients With Tropomyosin Receptor Kinase (TRK) Fusion-Positive Lung Cancer
00:00 - 00:00 | Presenter: Alexander Drilon
- Abstract
Loading... -
+
P53.03 - The Characteristics of FGFR Genetic Aberrations in Chinese Lung Cancer Patients
00:00 - 00:00 | Presenter: Xiuqin Zhang
- Abstract
Loading... -
+
P53.04 - Local Therapies vs. Specific TKIs as the Initial Treatment for Oligo-Recurrent Lung Adenocarcinoma With Driver Mutations
00:00 - 00:00 | Presenter: Yosuke Matsuura
- Abstract
Loading... -
+
P53.05 - Inhibition of Tumor Cell Intrinsic Complement Regulatory Proteins Leads to Decreased Tumor Growth in a Mouse Model of NSCLC
00:00 - 00:00 | Presenter: Emily K Kleczko
- Abstract
Loading... -
+
P53.06 - A Multi-Phase Quality Initiative to Improve Processes of Care for Non-small Cell Lung Cancer (NSCLC) in US Community Cancer Centers
00:00 - 00:00 | Presenter: Matthew Smeltzer
- Abstract
Loading... -
+
P53.07 - Clinical and Genomic Insights Into of Chinese Lung Cancer Patients with HER2 Amplification
00:00 - 00:00 | Presenter: Chengzhi Zhou
- Abstract
Loading... -
+
P53.08 - Concomitant Fibrates and Immunotherapy in Non-Small Cell Lung Cancer Patients in the Veterans Health Administration
00:00 - 00:00 | Presenter: William A Stokes
- Abstract
Loading...
-
+
P54 - Palliative and Supportive Care
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Palliative and Supportive Care
-
+
P54.01 - Analysis of the Support Needs of Lung Cancer Patients
00:00 - 00:00 | Presenter: Christie Lagogianni
- Abstract
Loading... -
+
P54.02 - Palliative Treatment of Tumor Stenoses of the Trachea and Bronchi
00:00 - 00:00 | Presenter: Vladyslav Severgin
- Abstract
Loading... -
+
P54.03 - Bilateral Indwelling Pleural Catheters
00:00 - 00:00 | Presenter: Avinash Aujayeb
- Abstract
Loading... -
+
P54.04 - Detecting Elevated Risk of Diminished Quality of Life Among Lung Cancer Patients by Using Wearable Devices
00:00 - 00:00 | Presenter: Maria Torrente
- Abstract
Loading... -
+
P54.05 - Stereotactic Radiotherapy for Brain Metastases in Patients With Lung Cancer: Cyberknife Experience
00:00 - 00:00 | Presenter: Süreyya Sarıhan
- Abstract
Loading... -
+
P54.06 - The FITNESS Study: Geriatric Assessment, Treatment Toxicity, and Biospecimen Collection Among Older Adults With Lung Cancer
00:00 - 00:00 | Presenter: Madison Grogan
- Abstract
Loading...
-
+
P55 - Patient Advocacy
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Patient Advocacy
-
+
P55.01 - Standard of Care Disparity in a Global Cancer Support Group: Examining an Advocate Survey to Inspire Change.
00:00 - 00:00 | Presenter: Jamie Gibbard
- Abstract
Loading... -
+
P55.02 - Robotic Surgery in Canada: Are Patients Willing to Pay Out-of-Pocket?
00:00 - 00:00 | Presenter: Yogita S. Patel
- Abstract
Loading... -
+
P55.03 - Results of The First Survey Using EORTC QLQ INFO25 on Information Acquisition and Satisfaction of Lung Cancer Patients in Japan
00:00 - 00:00 | Presenter: Takayuki Takahama
- Abstract
Loading...
-
+
P56 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Histopathology
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
P56.01 - Semiquantitative Assessment of Tumor Spread Through Air Spaces in a Historic Cohort of Lung Adenocarcinomas Following Open Surgical Resection
00:00 - 00:00 | Presenter: WEIWEI SHI
- Abstract
Loading... -
+
P56.02 - Novel Low Malignant Potential/Vascular Invasive (LMPVI) Grade is Superior to WHO 2015 and IASLC 2020 Adenocarcinoma Grade
00:00 - 00:00 | Presenter: Ilyas Yambayev
- Abstract
Loading... -
+
P56.03 - Prognostic Value of Tumor Spread Through Air Spaces in Patients With Lung Adenocarcinoma after Radical Surgery
00:00 - 00:00 | Presenter: Shiqi Chen
- Abstract
Loading... -
+
P56.04 - Pathological Features & Prognosis of NSCLC Patients With Enteric Adenocarcinomas Without Expression of TTF-1 and Napsin A
00:00 - 00:00 | Presenter: Daniel Christian Christoph
- Abstract
Loading... -
+
P56.05 - Detection Rate and Prognosis of Nodal-Micro Metastasis by IHC in pN0 Resectable Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: sophon - Siwachat
- Abstract
Loading... -
+
P56.06 - Clinical Significance and Potential Function of S100A10 in Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Jiyan Dong
- Abstract
Loading...
-
+
P57 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - ICI Biomarkers
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
P57.01 - Immunotherapy Fits Everyone? Prognostic Markers for Immune-checkpoint-Inhibitor (ICI) in Non-small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Susana Baptista de Almeida
- Abstract
Loading... -
+
P57.02 - Integration of Systemic / Tumor PD-L1 as a Predictive Biomarker of Clinical Outcome in Advanced NSCLC Patients Treated With Anti-PD-(L)1 Agents
00:00 - 00:00 | Presenter: Margarita Majem
- Abstract
Loading... -
+
P57.03 - Cellular Engagement and Interaction in the Tumor Microenvironment (TME) Predicts Response to ICI in Metastatic NSCLC
00:00 - 00:00 | Presenter: Angel Qin
- Abstract
Loading... -
+
P57.04 - Predicting Treatment Response to 1st- line Pembrolizumab in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients with High PDL1 Expression
00:00 - 00:00 | Presenter: Ian K. N. Janzen
- Abstract
Loading... -
+
P57.05 - Low Variant Allele Frequency of TP53 as a Biomarker for PD-1/PD-L1 Inhibitors in Lung Adenocarcinoma
00:00 - 00:00 | Presenter: Shouzheng Wang
- Abstract
Loading... -
+
P57.06 - EGFR Mutational Status and PD-L1 in Early-Stage Brazilian Non-Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Leticia Ferro Leal
- Abstract
Loading... -
+
P57.07 - The Scottish Immunotherapy Prognostic Score (SIPS) Predicts Response to First-Line Pembrolizumab for Metastatic Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Mark Stares
- Abstract
Loading... -
+
P57.08 - High Performance Radiomic Classifier to Predict the Response to Immunotherapy in Advanced NSCLC
00:00 - 00:00 | Presenter: Giulia Mazzaschi
- Abstract
Loading... -
+
P57.09 - Common Oncogenic Driver Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer of Smokers and Never Smokers
00:00 - 00:00 | Presenter: Chong Kin Liam
- Abstract
Loading... -
+
P57.10 - Clinicopathological Analysis of Anti-Tumor Immunology-Related Factors After Chemoradiotherapy for Lung Cancer
00:00 - 00:00 | Presenter: Misa Noguchi
- Abstract
Loading... -
+
P57.11 - The Role of Serum Proteomic Signature in Predicting Survival by PD-L1 Status in Patients With Non-Small Cell Lung Cancer Receiving Immunotherapy
00:00 - 00:00 | Presenter: Leeseul Kim
- Abstract
Loading... -
+
P57.12 - Clinical and Molecular Features of Chinese Lung Cancer Patients With Germline Mismatch Repair Gene Mutations
00:00 - 00:00 | Presenter: Jing Bai
- Abstract
Loading... -
+
P57.13 - Correlation of TP53/KMT2C co-mutation and Tumor Microenvironment in Lung Cancer
00:00 - 00:00 | Presenter: Xuhui Zhang
- Abstract
Loading... -
+
P57.14 - LRMP Associates With Immune Infiltrates and Acts as a Prognostic Biomarker in Lung Adenocarcinoma
00:00 - 00:00 | Presenter: xin jin
- Abstract
Loading... -
+
P57.15 - Safety and Efficacy of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer Patients With Low Creatinine Clearance Rate
00:00 - 00:00 | Presenter: Jia-Yi Deng
- Abstract
Loading... -
+
P57.16 - Inflammatory Markers as Predictors of Treatment Response and Survival in Patients With Non-Small Cell Lung Cancer Treated with PD-1 Inhibitors
00:00 - 00:00 | Presenter: Ioannis Gkiozos
- Abstract
Loading...
-
+
P58 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Predictive Biomarkers/ Pathology
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
P58.01 - Dysbiosis of Fecal Microbiome in Advanced Non-Small-Cell Lung Cancer
00:00 - 00:00 | Presenter: Xueqin Chen
- Abstract
Loading...
-
+
P59 - Predictive Tumor Based Assays/ Biomarkers/ Pathology - Targeted Therapies Biomarkers
- 00:00 - 00:00
- 9/08/2021
- Location: ePoster Hall
- Not for CME Credit
- Type: Posters
- Track: Predictive Tumor Based Assays/ Biomarkers/ Pathology
-
+
P59.01 - Clinical Characteristics of Patients With MET Amplification-Positive NSCLC After EGFR-TKI Therapy
00:00 - 00:00 | Presenter: Ji Hyun Lee
- Abstract
Loading... -
+
P59.02 - Profile of Next-Generation Sequencing (NGS) on MET exon 14 Skipping Mutation and MET Amplification in Lung Cancer: A Calibration Project in China
00:00 - 00:00 | Presenter: Wei Wu
- Abstract
Loading... -
+
P59.03 - Comparison of Two RNA-Based Platforms for Detection of Fusions and Met Splicing Variant in Non Small Cell Lung Cancer Samples
00:00 - 00:00 | Presenter: Clara Mayo-de-las-Casas
- Abstract
Loading... -
+
P59.04 - Molecular Characterization of Unactionable EGFR Mutation in Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: HuiTa Wu
- Abstract
Loading... -
+
P59.05 - Integration of Molecular Cancer Classification and NGS to Identify Metastatic Cancer Patients Eligible For Lung Cancer Directed Therapy
00:00 - 00:00 | Presenter: Kaushal Parikh
- Abstract
Loading... -
+
P59.06 - Prognostic Nutritional Index in Real-World Patients Receiving Systemic Therapy for Driver Mutation-Positive Metastatic NSCLC
00:00 - 00:00
- Abstract
Loading... -
+
P59.07 - Mutation Profile of BRAF in Chinese Non-Small Cell Lung Cancer Patients
00:00 - 00:00 | Presenter: Xinghao Ai
- Abstract
Loading... -
+
P59.08 - Identifying the Origin of Lung-Specific Cancer of Unknown Primary Based on Comprehensive Genomic Profiling Optimized With DNA Methylation
00:00 - 00:00 | Presenter: Yun Fan
- Abstract
Loading... -
+
P59.09 - Landscape of Targetable Genomic Alterations in Hispanic/Latinx Patients With Non-Small Cell Lung Cancers
00:00 - 00:00 | Presenter: Ana Isabel Velazquez
- Abstract
Loading... -
+
P59.10 - A Sneak Peak in the Future World of EGFR Mutations: ML Based PFS Differences Between Del 19 and L858R
00:00 - 00:00 | Presenter: Ullas Batra
- Abstract
Loading... -
+
P59.11 - Real-World Data of NGS Diagnostic Biomarker Testing for Lung Cancer Patients in Japan
00:00 - 00:00 | Presenter: Toshiaki Takahashi
- Abstract
Loading... -
+
P59.12 - KRAS Mutation Subtypes in Non-Small Cell Lung Cancer and Clinical Outcomes: A Single Centre Experience
00:00 - 00:00 | Presenter: Alexander Patrick Davis
- Abstract
Loading... -
+
P59.13 - The Prediction Performance of TP53 / RB1 Co-Mutation on Small-Cell Lung Cancer Transformation in Patients With Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Zaiwen Fan
- Abstract
Loading... -
+
P59.14 - Concordance and Performance of ddPCR Compared to NGS for The Detection of KRAS G12C Mutation
00:00 - 00:00 | Presenter: Andres Felipe Cardona Zorrilla
- Abstract
Loading... -
+
P59.15 - Is CD73 Expression a Druggable Mechanism of Resistance in EGFR-TKI-Treated EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)?
00:00 - 00:00 | Presenter: Inger Johanne Eide
- Abstract
Loading... -
+
P59.16 - Characterizing the Tumour-Immune Microenvironment in EGFR Mutant NSCLC
00:00 - 00:00 | Presenter: Ken O'Byrne
- Abstract
Loading... -
+
P59.17 - EGFR Mutation Status, Liver Metastasis, and Overall Survival in Advanced Lung Adenocarcinoma Patients
00:00 - 00:00 | Presenter: Preet Walia
- Abstract
Loading... -
+
P59.18 - Evaluation of ROS1 Expression in a Large Cohort of Early Stage Lung Cancer
00:00 - 00:00 | Presenter: Anne Pernille Harlem Dyrbekk
- Abstract
Loading... -
+
P59.19 - MET Alterations and Co-Drivers With Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer
00:00 - 00:00 | Presenter: Maritza Ramos-Ramirez
- Abstract
Loading... -
+
P59.20 - Natural History of KRAS Mutant Non-Small-Cell Lung Cancer in the Immunotherapy Era: A Single-Centre Retrospective Study
00:00 - 00:00 | Presenter: Paolo Bironzo
- Abstract
Loading... -
+
P59.21 - Impact of Reflex Testing on Pathology Based Molecular Testing in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
00:00 - 00:00 | Presenter: Melina E. Marmarelis
- Abstract
Loading... -
+
P59.22 - Biomarker Testing for Advanced Lung Cancer by Next-Generation Sequencing in Real World Practice
00:00 - 00:00 | Presenter: Jose Nicolas Minatta
- Abstract
Loading... -
+
P59.23 - Biomarker Testing for Non-Small Cell Lung Cancer at a Tertiary Referral Hospital in Ireland: Challenges and Opportunities
00:00 - 00:00 | Presenter: Philip Bredin
- Abstract
Loading... -
+
P59.24 - Genomic Abnormalities in Malignant Pleural Effusion of Lung Cancer Patients Detected by Multiplex Ligation-Dependent Probe Amplification
00:00 - 00:00 | Presenter: Caroline Silvério Faria
- Abstract
Loading... -
+
P59.25 - Prognostic and Treatment Characteristics of Metastatic KRAS G12C Mutant NSCLC
00:00 - 00:00 | Presenter: Anifat Elegbede
- Abstract
Loading... -
+
P59.26 - Comparison of RT-PCR, NGS and FISH/IHC Methods in Detection of Gene Fusions
00:00 - 00:00 | Presenter: Yue Pu
- Abstract
Loading... -
+
P59.27 - Complementary Utility of Combined ALK/ROS1 FISH with Immunohistochemistry for ALK/ROS1 Rearrangement Testing in Lung Cancer
00:00 - 00:00 | Presenter: Aruna Nambirajan
- Abstract
Loading... -
+
P59.28 - Protocol Adaptation for gDNA Extraction of FFPE Samples of Lung Adenocarcinoma Tissue and Related Mediastinal Lymph Nodes
00:00 - 00:00 | Presenter: Caroline Silvério Faria
- Abstract
Loading... -
+
P59.29 - Frequency of PIK3CA Mutations and Therapeutic Outcomes in NSCLC
00:00 - 00:00 | Presenter: Guillermo Martos
- Abstract
Loading... -
+
P59.30 - Genomic Landscape of Lung Cancer in the Young
00:00 - 00:00 | Presenter: Rossana Ruiz
- Abstract
Loading... -
+
P59.31 - A High Number of Co-Current Genetic Alterations Is Associated With Poor Survival in EGFR Mutated Metastatic NSCLC Patients
00:00 - 00:00 | Presenter: David Heredia
- Abstract
Loading... -
+
P59.32 - Physician Attitudes Toward Genetic Testing and Targeted Therapy for Advanced NSCLC Patients in China: A Nationwide Survey
00:00 - 00:00 | Presenter: Xiao Meng
- Abstract
Loading...
first
prev
